| Serial Number | 99538231 |
| Word Mark | B-FREE |
| Filing Date | Tuesday, December 9, 2025 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Monday, April 13, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Indication of Colors claimed | The color(s) Red, black and white is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of the words B-FREE appearing in stylized capital letters; the stylized letter B and the hyphen are encompassed with four red dotted lines varying in sizes beginning at the top of the letter B and extending outwards to include the hyphen, the lines make a semi-circle to encompass the letter B and the hyphen. |
| Goods and Services | promoting disease awareness in relation to tick-borne diseases including babesiosis |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 9, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | 60° Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20036 US |
| Event Date | Event Description |
| Tuesday, December 9, 2025 | NEW APPLICATION ENTERED |
| Tuesday, December 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, April 2, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 2, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, April 13, 2026 | ASSIGNED TO EXAMINER |